Stellarex drug‐coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12‐Month results from a prospective, multicenter, single‐arm study

OBJECTIVES: The purpose of this study was to assess the safety and performance of Stellarex Drug‐coated balloon (DCB). BACKGROUND: DCB coatings differ in excipients, paclitaxel dose, and coating morphologies. Due to these differences, a class effect with DCBs has not been demonstrated. Consequently,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Catheter Cardiovasc Interv
Main Authors: Schroë, Herman, Holden, Andrew H., Goueffic, Yann, Jansen, Shirley J., Peeters, Patrick, Keirse, Koen, Ito, Wulf, Vermassen, Frank, Micari, Antonio, Blessing, Erwin, Jaff, Michael R., Zeller, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Peripheral Vascular Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5836976/
https://ncbi.nlm.nih.gov/pubmed/29086462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccd.27348
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados